Upstaza

(eladocagene exuparvovec)

Uses, side effects, dosage information & price range

PTC Therapeutics International Limited

About this medicine

Upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic L amino acid decarboxylase (AADC) deficiency with a severe phenotype (see section 5.1).

Key Information

Salt / Composition

eladocagene exuparvovec

Category

Other alimentary tract and metabolism products;Enzymes

Manufacturer

PTC Therapeutics International Limited

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.